echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Original research/reference + evaluation≥ 4 companies have more than 92, and the national procurement has not reached nearly 100

    Original research/reference + evaluation≥ 4 companies have more than 92, and the national procurement has not reached nearly 100

    • Last Update: 2022-10-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    In September, there are not many new generic products approved for consistency evaluation as a whole, and the number of approvals approved is quite large, so far nearly 5,000 approvals have been approved, about 760 generic names (calculated according to the rules of collective procurement and consolidation) have been evaluated (including 2, 3, and 4 of the newly registered classification), and 800+ reference preparation products have not been evaluated by enterprises (63 batches of opinion drafts and 59 batches of official drafts).

    If the eighth batch is still a chemical drug, according to the inclusion conditions of the seventh batch, at present, there are more than 92 original research/reference + evaluation ≥ 4 (including patent has not expired, patent dispute, no reference recommendation, toxin and hemp intensive release, shortage of drugs, narrow treatment window, etc.
    , have been marked).

    Marked

    1.
    Evaluated products and several original research details

    1.
    Evaluated products and several original research details

    (Information source: NMPA CDE Drug Rongyun Fengyun Drug Talk Collation)

    2.
    Reviewed products and several companies, original research and their specifications, and competition pattern details

    , evaluated products and several companies, original research and its specifications, competition pattern details

    (Information source: NMPA CDE Drug Rongyun Fengyun Drug Talk Collation)

    A note about statistics:

    Notes on statistics

    1.
    Statistics are based on the market holders of products, no longer statistics of production enterprises, and the inclusion conditions of national procurement are unified
    .

    2.
    The data is manual statistics, there will inevitably be errors, if there is an error in the company's information statistics, please understand; If you find it, please correct it, thank you very much!

    3.
    NMPA and database error: At present, all mainstream databases on the market that have queried evaluation information have errors in evaluation information, such as: hydroxyethyl starch 130/0.
    4 sodium chloride, this product is currently displayed in all databases are evaluated, but at present, this product has not been evaluated, and the product will not have an evaluation mark, so it does not meet the conditions for
    inclusion in centralized procurement.

    3.
    NMPA and database error

    4.
    The data is only for over-evaluation, please reprint and do not link with national procurement, so as not to mislead!

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.